My outlook on CTXRI see a nice potential for a W pattern (black dots), current trend (red dots) looks like we may test .80 which would be a great buy IMO with potential catalysts (ph3 results & stem cell product) that could get us to the 💵 and 💰lines Longby Onek_2_1m113
CTXR BreakoutCTXR closed above the 23.6 Fibonacci level and broke thru the descending trendline to close above resistance. Im looking for it to increase up the Fibonacci scale. $1.24, $1.38 and $1.52 in the short term. Longby Master_of_Fine_Charts14141
$CTXR Bullish Pitchfork & Divergence after strong 8-kOversold conditions with bullish divergence signals on the loom after a strong 8-k with optimistic outlooks on Mino-Lok and COVID/ARDS treatmentLongby UnknownUnicorn6214853111
$CTXR broke through key resistance zone - now supportGood realization of gains on COVID news. New support and good upside to recent highsLongby UnknownUnicorn62148531
Citius Pharmaceuticals, Inc. 50% upsideCitius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.Longby DEXWireNews1111
$CTXR Bullish - BB break + 3hr SAR flipAlso bullish on Stoch & Wooddies CCILongby UnknownUnicorn6214853113
CTXR 30 min chart above SMA 200 (Bullish Pattern)I was looking at this stock and it have a nice bullish pattern because those candles are above the SMA200 , If the candles keep doing trades above that EMA Line and Above SMA 200 it have a high chance to reach that $1.40. Price Fell after reaching $2.00 that is a good signal of a bounce back if candles stay above SMA 200. MACD looks good for me and the RSI is not that bad. All this analysis is in base of stock chart. No fundamentals on it. ***Remember**** This is only my Idea, don't buy or sell because of my idea. Do your own research in the company before deciding either buy or sell at your own risk.Longby Making_Profit114
CTRXCTRX = 50000 LONG from 0.85 TP1 1.5 TP2 2.5 TP3 5$ Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.Longby mauretto432Updated 4414
CTXRPENNANT/ DESCENDING TRIANGLE ON CTXR. WITH CATALYST AHEAD OF PHASE 3 DATA FOR CATHETER RELATED BLOOD STREAM INFECTION 2H 2020 NASDAQ:CTXR , SHOULD SEE A BREAKOUT FOR A NICE RUNLongby luistoxkz24Updated 114
CTXR is going to test upper resistance. Hello, What is CTXR? Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. News Citius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy. My Thoughts For You If you're not sure how to get into a trade or when to take profits then check out this tutorial I have created in the comments section under "My Trade Advice For You" Good Luck, Cheers! Be sure to comment, follow, like, and check out my profile for more trade ideas!Longby keifer2219
CTRX Trending towards bullish territoryThis stock apppears to be skyrocketing with my projected trendline. Buy now while cheap!Longby stampsmike6
Strong move comingCTXR has shown a nice breakout with heavy volume, followed by a pullback to the crime scene on low volume while RSI hovering just around 50, it is now moving above the 50 MA and breaking out of the second downtrendline, a good risk/reward setupLongby Charlestrad3rUpdated 116
Citius Pharmaceuticals, Inc. trade setupCitius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.by DEXWireNews18
Looking to buy the dipCitius recently Announced Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial Top line data due for 1H 2020 insider Own 42.50% Shs Float 16.64M Market Cap 28.70M Increase in hedge fund holdings Longby Charlestrad3r3
CTXR Bullish chartUnusual amount of money in a small relative price range. A bigger, totally move is on the way.Longby TechnicalAnalysiss0